CIPDB › China Industry › Chemicals › Chemical Reagent
T/S/Rta for Losing Belly Fat Slimming Manufacturer Supply 99% Pure Janoshik Tested 5/10/30/60mg Vials Once-Weekly1
Chemical ReagentPeptidesPeptide
Suzhou Redgia Biotech Co., Ltd.
Preview:
Product Description T/S/Rta for Losing Belly Fat Slimming Manufacturer Supply 99% Pure Janoshik Tested 5/10/30/60mg Vials Once-WeeklyProduct nameTzAppearanceWhite powderPurity99%StorageKeep in a cool, dry, dark location in a tightly sealed container or cylinder.Shelf Life24 MonthsApplication:Novel Slimming peptides (Rta,TZ,Cagrin,CagrinS)were approved wellness for Fat Reduce. They are newestclass of chemical products better known for its ability to improve blood sugar control. Obesity is a complex disease that occurs when an individual's weight is higher than what is considered healthy for his/her height.According to the CDC, people with a body mass index (BMI) between 25 and 29.9 are considered overweight, and people with aBMI of 30 or higher are considered obese.Slimming peptides works in the treatment of obesity by targeting three different hunger regulating hormones:1.GIP (gastric inhibitory peptide or glucose-dependent insulinotropic polypeptide) is an incretin hormone that is released from thegut after eating. It stimulates the beta-cells in the pancreas to secrete.2.G-LP-1r (glucagon-like peptide-1r) is also an incretin hormone that stimulates the beta-cells to secrete.- glucagon is a hormone secreted from the alpha-cells in the pancreas. It stimulates glucose production in the liver and helpsmaintain adequate plasma glucose concentrations.The peptide has been nicknamed 'triple-G' because it is an agonist of all three receptors.Phase 2 clinical trial results published in The New England Journal of Medicine show Slimming peptides achieved up to 17.5%mean weight reduction at 24 weeks in adults with obesity and overweight. In a secondary endpoint, rta demonstrated amean weight reduction up to 24.2% at 48 weeks.Slimming pepides as an injection that are administered once-weekly.In the research items,they showed glucose control and Fat burning, type 2 diabetes mellitus (T2DM). They can be just used for the research purpose.Normally, They will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details,please refer to the manual:Handling and Storage of Synthetic Peptides.Benifits:Semg&Cagris are a single agonist peptide ,Semg&Cagris can be used for the research of obesity treatment or cravingssuppression,T2dm Therapies,and so on.Tz&Cagris are a Dual agonists peptide ,Tz&Cagris can be used for the research of Anti-obesity or appetite Suppression and soon.Rta is a triple agonist peptide ,Rta can be used for the research of Anti-obesity,burn fat,boost energy.Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details,please refer to the manual:Handling and Storage of Synthetic Peptides.What is Rta?Rta is a synthetic peptide, known for its unique action as a triple receptor agonist. This peptide, also referred to by its code nameLY-3437943, targets three key receptors: glucagon-like peptide-1 (G-LP-1r,GIP),and glucagon (GCG). Each of these receptorsplays an important role in regulating metabolism, with a particular focus on slimming,energy expenditure, and blood glucoselevels.The compound is designed to activate these three receptors simultaneously, with special emphasis on GIP, to help managemetabolic conditions like type 2 diabetes and support Slimming. Rta is composed of 39 amino acids and is structurallyengineered to maintain stability and prolonged activity in the body. This design makes it an attractive candidate for improvingmetabolic health and supporting weight management.Rta's mode of action is what sets it apart from other peptides. Its ability to address multiple aspects of metabolic regulation couldoffer significant benefits for individuals seeking to manage their weight or improve glycemic control.Important details for researchers:1.Synthetic design: Though primarily targeting GIP receptors, rta has been designed to also activate G-LP-1r and GCGreceptors, enhancing its effects in regulating metabolism and supporting weight management. 2.Extended activity: The peptide includes a fatty acid component that enhances stability, allowing for less frequent dosing,typically once a week. 3.Clinical trials: Rta is being evaluated in Phase-3 clinical trials, primarily for its effectiveness in supporting slimming,with positive results in improving glycemic control and reducing body weight. 3.Regulatory status: Currently, the peptide is available for research purposes, though it has not yet been approved by regulatorybodies such as the FDA.For Research Purpose Only. Purchasing objects are required to be companies and labs, not for personal use.
Purchasing Agent
Note: Send your message to supplier or manufacturer.
Welcome to our Professional and comprehensive procurement services...